TheraRadar
Clinical-Stage Companies / Hangzhou Sciwind Biosciences

Hangzhou Sciwind Biosciences

Pre-Approval PRO BETA
13
Total Trials
7
Phase 3
3
Phase 2
5
Recruiting
169
Score

Pipeline by Phase

Phase 3
7
Phase 2
3
Phase 1
5

Therapeutic Focus

Obesity Weight Management OSA - Obstructive Sleep Apnea T2DM Type 2 Diabetes Mellitus

Clinical Trials (13)

NCT07387094 Phase 3 RECRUITING

A Study of XW003 in Obese Participants With Obstructive Sleep Apnea But Not Receive Positive Airway Pressure Therapy

Started: 2/9/2026

NCT07434050 Phase 3 RECRUITING

A Study of XW003 in Obese Participants With Obstructive Sleep Apnea Receiving Positive Airway Pressure Therapy

Started: 3/2/2026

NCT07734311 Phase 3 RECRUITING

A Study of Econoglutide Injection in Obese Participants With Knee Osteoarthritis (KOA)

Started: 8/3/2026

NCT05680155 Phase 3 COMPLETED

A Phase 3 Study to Evaluate the Efficacy of XW003 Compared With Placebo in T2DM Patients

Started: 12/29/2022

NCT05680129 Phase 3 COMPLETED

A Phase 3 Study to Evaluate the Efficacy of XW003 Compared With Dulaglutide in Participants With T2DM

Started: 1/10/2023

NCT05813795 Phase 3 COMPLETED

A Phase 3 Study to Evaluate the Efficacy of XW003 in Adults With Overweight or Obesity

Started: 4/5/2023

NCT07836270 Phase 3 NOT YET RECRUITING

A Study of Ecnoglutide Injection in Overweight or Obese Chinese Adolescents

Started: 10/31/2026

NCT07073417 Phase 2 ACTIVE NOT RECRUITING

A Study to Compare XW003 Injection and Semaglutide Injection in Chinese Adults With Obesity (SLIMMER-UP-SWITCH)

Started: 7/28/2025

NCT07243171 Phase 1 RECRUITING

A Phase Ib/IIa Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Ecnoglutide Tablets in Chinese Participants With Overweight or Obesity

Started: 11/18/2025

NCT07143227 Phase 1 COMPLETED

A Study of XW003 Injection in Chinese Adolescents With Obesity

Started: 8/25/2025

NCT05779995 Phase 1 COMPLETED

A Study To Evaluate the Safety of XW001 Inhalation in Children With RSV

Started: 4/20/2023

NCT06335134 Phase 1 COMPLETED

A Drug-Drug Interaction Study Between XW003 and Metformin, Warfarin, Rosuvastatin or Digoxin

Started: 7/14/2023

NCT05642403 Phase 1 COMPLETED

A Study of XW001 in Healthy Adult Subjects

Started: 1/3/2021

Drug Candidates

XW003 injection ecnoglutide tablets Ecnoglutide XW001 Ecnoglutide high dosage Ecnoglutide low dosage Ecnoglutide Low Dosage Ecnoglutide Medium Dosage Ecnoglutide High Dosage Ecnoglutide Injection
Activity Status: Active
Last Trial Started: 10/31/2026
Last Trial Ended: 4/18/2026
Trials (12 months): 5
Completed Trials: 7
Data sourced from ClinicalTrials.gov. This company has no FDA-approved drugs.